Organophosphate inhibition of human heart muscle cholinesterase isoenzymes

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 183-192

  Chemnitius, Jörg Michael ^a   Sadowski, Rita ^a   Winkel, Holger ^a   Zech, Ronald ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase isoenzymes; Human heart muscle; Inhibition kinetics; Organophosphorus compounds

Indexed keywords

ACETYL BETA METHYLTHIOCHOLINE; ACETYLTHIOCHOLINE; BUTYRYLTHIOCHOLINE; CHOLINESTERASE; ISOENZYME; MIPAFOX; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SPECIFICITY; FEMALE; HEART LEFT VENTRICLE MUSCLE; HUMAN; HYDROLYSIS; INHIBITION KINETICS; MALE; NONHUMAN; SWINE;

ACETYLTHIOCHOLINE; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BUTYRYLTHIOCHOLINE; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; FEMALE; HEART VENTRICLES; HUMANS; ISOENZYMES; ISOFLUROPHATE; MALE; MIDDLE AGED; MYOCARDIUM; PHOSPHORIC ACID ESTERS; SWINE; THIOCHOLINE;

MAMMALIA;

EID: 0033002908     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00027-7     Document Type: Conference Paper

References (28)

1. Opie L.H. The Heart. Physiology and Metabolism. 1991;Raven Press, New York.
2. Kunkel M.T., Peralta E.G. Identification of domains conferring G protein regulation on inward rectifier potassium channels. Cell. 83:1995;443-449.
3. +-channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflug. Arch. 407:1986;264-274.
4. +-channel in heart. Nature. 325:1987;321-326.
5. Pappano A.J., Inoue D. Development of different electrophysiological mechanisms for muscarinic inhibition of atria and ventricles. Fed. Proc. 43:1984;2607-2612.
6. Fleming J.W., Strawbridge R.A., Watanabe A.M. Muscarinic receptor regulation of cardiac adenylate cyclase activity. J. Mol. Cell. Cardiol. 19:1987;47-61.
7. Loewi O. Über humorale Übertragbarkeit der Herznervenwirkung. Pflug. Arch. 189:1921;239-242.
8. Brown J.H., Wetzel G.T., Dunlap J. Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors. J. Pharmacol. Exp. Ther. 223:1982;20-24.
9. Watts J.A., Hoogmoed R.P. Dimethyl sulfoxide inhibition of acetylcholinesterase in the mammalian heart. Biochem. Pharmacol. 33:1984;365-369.
10. Henning R.K., Masuda Y., Yang T., Levy M.N.L. Rate of acetylcholine hydrolysis affects the phase dependency of cardiac responses to vagal stimulation. Cardiovasc. Res. 21:1987;169-176.
11. Gonzalez R., Campos E.O., Moran S., Inestrosa N.C. Characterization of acetylcholinesterase from human heart auricles: evidence for the presence of a G-form sensitive to phosphatidylinositol-specific phospholipase c. Gen. Pharmacol. 22:1991;107-110.
12. Ellman G.L., Cortney D., Andres V., Featherstone F.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
13. Chemnitius J.-M., Chemnitius G.-C., Haselmeyer K.-H., Kreuzer H., Zech R. Cholinesterases of heart muscle. Characterization of multiple enzymes using kinetics of irreversible organophosphorus inhibition. Biochem. Pharmacol. 43:1992;823-829.
14. Chemnitius J.-M., Dewald K., Kreuzer H., Zech R. Computerized analysis of covalent inhibition kinetics for identification of heart muscle cholinesterase and brain carboxylesterase isoenzymes. Design of differential inhibition assays. Chem.-Biol. Interact. 87:1993;239-244.
15. Chemnitius J.-M., Haselmeyer K.-H., Gonska B.-D., Krenzer H., Zech R. Mipafox differential inhibition assay for heart muscle cholinesterases: substrate specificity and inhibition of three isoenzymes by physostigmine and quinidine. Gen. Pharmacol. 28:1997;567-575.
16. Chemnitius J.-M., Haselmeyer K.-H., Zech R. Identification of isoenzymes in cholinesterase preparations using kinetic data of organophosphate inhibition. Anal. Biochem. 125:1982;442-452.
17. Gnatt A., Ginzberg D., Lieman-Hurwitz J., Zamir R., Zakut H., Soreq H. Human acetylcholinesterase and butyrylcholinesterase are encoded by two distinct genes. Cell. Mol. Neurobiol. 11:1991;91-104.
18. Allderdice P.W., Gardner H.A., Galutira D., Lockridge O., LaDu B.N., McAlpine P.J. The cloned butyrylcholinesterase (BChE) gene maps to a single chromosome site, 3q26. Genomics. 11:1991;452-554.
19. Getman D.K., Eubanks J.H., Camp S., Evans G.A., Taylor P. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am. J. Hum. Genet. 51:1992;170-177.
20. Liang-Xiong Fu M., Schulze W., Wallukat G., Hjalmarson A., Hoebeke J. Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor. J. Mol. Cell. Cardiol. 27:1995;427-436.
21. Goin J.C., Borda E., Perez Leiros C., Storino R., Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J. Auton. Nerv. Syst. 47:1994;45-52.
22. Goin J.C., Perez Leiros C., Borda E., Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor. Functional and pathological implications. FASEB J. 10:1997;77-83.
23. Kolman B.S., Verrier R.L., Lown B. Effect of vagus nerve stimulation upon excitability of the canine ventricle. Am. J. Cardiol. 37:1976;1041-1045.
24. Niklasson U., Wiklund U., Bjerle P., Oloofsson B.-O. Heart-rate variation: what are we measuring? Clin. Physiol. 13:1993;71-79.
25. Bigger J.T., Fleiss J.L., Rolnitzky L.M., Steinman R.C. Stability over time of heart rate period variability in patients with previous myocardial infarction and ventricular arrhythmias. Am. J. Cardiol. 69:1992;718-723.
26. Courmel P., Hermida J.S., Wennerblom B., Leenhardt A., Maison-Blanche P., Cauchemez B. Heart rate variability in left ventricular hypertrophy and heart failure, and the effects of beta-blockade. Eur. Heart J. 12:1991;412-422.
27. Casolo G.C., Stroder P., Signorini C., Calzolari F., Zucchini M., Balli E., Sulla A., Lazzerini S. Heart rate variability during the acute phase of myocardial infarction. Circulation. 85:1992;2073-2079.
28. Chemnitius J.-M., Schahmirzadi F., Gonska B.-D., Kreuzer H., Zech R. Indirect parasympathomimetic activity of the class-III antiarrhythmic substance D/L-sotalol in vitro: reversible inhibition of cholinesterase isoenzymes from blood and the human central nervous system. Pharmacol. Res. 34:1996;193-200.